News
The vaccine will offer protection against H5N1 and is projected to be effective against future viral mutations.
The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback